Independent fund research. Built on SEC filings.

How we research funds

ETF · Technology Sector · VanEck

BBH Holdings: What VanEck Biotech ETF Owns

Ticker BBH · · Holdings as of Jun 30, 2026

Expense ratio
0.35%$35/yr per $10k
5-yr return
+2.7%annualized
1-yr return
+21.2%as of Dec 2025
Net assets
$395.6Mall share classes
Holdings
25

Bottom line

What does BBH hold?

BBH held 25 positions as of Jun 30, 2026. Its largest holding is Amgen Inc at 15.25% of the fund, and the top 10 positions add up to 70.3%. By asset type it is 100% stocks, 0% cash & short-term funds.

Updated Aug 26, 2026

BBH top 25 holdings

#HoldingType% of fundValue
1 Amgen Inc Stocks 15.25%$60.3M
2 Gilead Sciences Inc Stocks 12.79%$50.6M
3 Vertex Pharmaceuticals Inc Stocks 9.10%$36.0M
4 Regeneron Pharmaceuticals Inc Stocks 6.21%$24.6M
5 Revolution Medicines Inc Stocks 5.27%$20.9M
6 Argenx SE Stocks 4.97%$19.7M
7 Natera Inc Stocks 4.92%$19.5M
8 IQVIA Holdings Inc Stocks 4.31%$17.0M
9 Alnylam Pharmaceuticals Inc Stocks 3.83%$15.2M
10 Biogen Inc Stocks 3.63%$14.3M
11 Moderna Inc Stocks 3.36%$13.3M
12 Illumina Inc Stocks 3.17%$12.5M
13 United Therapeutics Corp Stocks 2.83%$11.2M
14 BeOne Medicines Ltd Stocks 2.81%$11.1M
15 Insmed Inc Stocks 2.67%$10.6M
16 Incyte Corp Stocks 2.49%$9.9M
17 Neurocrine Biosciences Inc Stocks 2.08%$8.2M
18 BioNTech SE Stocks 1.94%$7.7M
19 Icon Plc Stocks 1.90%$7.5M
20 Bio-Techne Corp Stocks 1.54%$6.1M
21 Charles River Laboratories International Inc Stocks 1.50%$5.9M
22 BioMarin Pharmaceutical Inc Stocks 1.34%$5.3M
23 Qiagen Nv Stocks 1.06%$4.2M
24 Tempus AI Inc Stocks 0.98%$3.9M
25 State Street Global Advisors
State Street Navigator Securities Lending Government Money…
Cash & short-term funds 0.06%$233.7K

Source: SEC Form N-PORT, period ended Jun 30, 2026, filed Aug 26, 2026

Asset mix

Stocks100.0%
Cash & short-term funds0.1%

Country exposure

CH2.8%
DE1.9%
IE1.9%
NL6.0%
US87.3%